QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.55 (+1.12%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-1.80%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.55 (+1.12%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-1.80%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.55 (+1.12%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-1.80%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.55 (+1.12%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-1.80%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
NASDAQ:NRIM

Northrim BanCorp (NRIM) Stock Forecast, Price & News

$37.91
+0.19 (+0.50%)
(As of 05/31/2023 ET)
Compare
Today's Range
$37.41
$38.00
50-Day Range
$34.55
$47.57
52-Week Range
$33.29
$56.77
Volume
19,135 shs
Average Volume
26,260 shs
Market Capitalization
$214.19 million
P/E Ratio
7.72
Dividend Yield
6.33%
Price Target
N/A

Northrim BanCorp MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.50% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
1.13mentions of Northrim BanCorp in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$283,706 Bought Last Quarter
Proj. Earnings Growth
0.39%
From $5.15 to $5.17 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.72 out of 5 stars

Finance Sector

3rd out of 901 stocks

Federal Savings Institutions Industry

1st out of 45 stocks


NRIM stock logo

About Northrim BanCorp (NASDAQ:NRIM) Stock

Northrim Bancorp, Inc. operates as a bank holding company. The firm provides personal, business and commercial banking products and services. It operates through the following segments: Community Banking and Home Mortgage Lending. The Community Banking segment offers loan and deposit products to business and consumer customers in the company's market areas. The Home Mortgage Lending segment focuses on the origination and sale of mortgage loans for 1-4 family residential properties. The company was founded on December 4, 1990 and is headquartered in Anchorage, AK.

Receive NRIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Northrim BanCorp and its competitors with MarketBeat's FREE daily newsletter.

NRIM Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Northrim BanCorp (NASDAQ:NRIM) Lifted to Buy at StockNews.com
Northrim BanCorp: Dividend Insights
Northrim (NRIM) Rewards Investors With a 20% Dividend Hike
See More Headlines
Receive NRIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Northrim BanCorp and its competitors with MarketBeat's FREE daily newsletter.

NRIM Company Calendar

Last Earnings
10/28/2021
Ex-Dividend for 3/17 Dividend
3/08/2023
Dividend Payable
3/17/2023
Today
5/31/2023
Ex-Dividend for 6/16 Dividend
6/07/2023
Dividend Payable
6/16/2023
Next Earnings (Estimated)
7/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Federal savings institutions
Sub-Industry
Regional Banks
Sector
Finance
Current Symbol
NASDAQ:NRIM
CUSIP
66676210
Employees
451
Year Founded
1990

Profitability

Net Income
$30.74 million
Pretax Margin
25.60%

Debt

Sales & Book Value

Annual Sales
$134.40 million
Cash Flow
$6.21 per share
Book Value
$39.72 per share

Miscellaneous

Free Float
5,424,000
Market Cap
$212.84 million
Optionable
Not Optionable
Beta
0.65

Social Links


Key Executives

  • Jeo Schierhorn
    Chairman, Co-President, CEO & Co-COO
  • Michael G. Huston
    Co-President & Chief Lending Officer
  • Amber Zins
    Chief Operating Officer & Executive VP
  • Jed W. BallardJed W. Ballard
    Chief Financial Officer & Executive Vice President
  • Benjamin D. Craig
    Chief Information Officer & Executive VP













NRIM Stock - Frequently Asked Questions

How have NRIM shares performed in 2023?

Northrim BanCorp's stock was trading at $54.57 on January 1st, 2023. Since then, NRIM stock has decreased by 31.0% and is now trading at $37.67.
View the best growth stocks for 2023 here
.

Are investors shorting Northrim BanCorp?

Northrim BanCorp saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 27,800 shares, a decline of 53.8% from the April 30th total of 60,200 shares. Based on an average trading volume of 31,700 shares, the short-interest ratio is currently 0.9 days. Currently, 0.5% of the company's stock are short sold.
View Northrim BanCorp's Short Interest
.

When is Northrim BanCorp's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our NRIM earnings forecast
.

How were Northrim BanCorp's earnings last quarter?

Northrim BanCorp, Inc. (NASDAQ:NRIM) posted its earnings results on Thursday, October, 28th. The financial services provider reported $1.42 EPS for the quarter, missing the consensus estimate of $1.44 by $0.02. The financial services provider had revenue of $33.09 million for the quarter, compared to the consensus estimate of $33.70 million. Northrim BanCorp had a net margin of 20.51% and a trailing twelve-month return on equity of 13.05%.

How often does Northrim BanCorp pay dividends? What is the dividend yield for Northrim BanCorp?

Northrim BanCorp declared a quarterly dividend on Friday, May 26th. Stockholders of record on Thursday, June 8th will be paid a dividend of $0.60 per share on Friday, June 16th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 6.37%. The ex-dividend date is Wednesday, June 7th.
Read our dividend analysis for NRIM
.

What ETFs hold Northrim BanCorp's stock?

ETFs with the largest weight of Northrim BanCorp (NASDAQ:NRIM) stock in their portfolio include AdvisorShares Dorsey Wright Micro-Cap ETF (DWMC), First Trust NASDAQ ABA Community Bank Index Fund (QABA),

Is Northrim BanCorp a good dividend stock?

Northrim BanCorp (NASDAQ:NRIM) pays an annual dividend of $2.40 per share and currently has a dividend yield of 6.30%. NRIM has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 48.88%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, NRIM will have a dividend payout ratio of 46.42% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NRIM.

What is Joe Schierhorn's approval rating as Northrim BanCorp's CEO?

2 employees have rated Northrim BanCorp Chief Executive Officer Joe Schierhorn on Glassdoor.com. Joe Schierhorn has an approval rating of 100% among the company's employees. This puts Joe Schierhorn in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Northrim BanCorp own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Northrim BanCorp investors own include Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ), Walt Disney (DIS), Enterprise Products Partners (EPD), Altria Group (MO), AbbVie (ABBV), Gilead Sciences (GILD), Home Depot (HD) and AT&T (T).

What is Northrim BanCorp's stock symbol?

Northrim BanCorp trades on the NASDAQ under the ticker symbol "NRIM."

Who are Northrim BanCorp's major shareholders?

Northrim BanCorp's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.46%), Dimensional Fund Advisors LP (8.69%), Ameriprise Financial Inc. (4.36%), LSV Asset Management (2.76%), Acadian Asset Management LLC (2.38%) and Ancora Advisors LLC (1.41%). Insiders that own company stock include Aaron Michael Schutt, Anthony Drabek, David G Wight, David J Mccambridge, David W Karp, Jed W Ballard, John C Swalling, Joseph M Schierhorn, Joseph Marushack, Karl L Hanneman, Krystal Murphy Nelson, Larry S Cash, Linda C Thomas and Marilyn Romano.
View institutional ownership trends
.

How do I buy shares of Northrim BanCorp?

Shares of NRIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Northrim BanCorp's stock price today?

One share of NRIM stock can currently be purchased for approximately $37.67.

How much money does Northrim BanCorp make?

Northrim BanCorp (NASDAQ:NRIM) has a market capitalization of $212.84 million and generates $134.40 million in revenue each year. The financial services provider earns $30.74 million in net income (profit) each year or $4.91 on an earnings per share basis.

How many employees does Northrim BanCorp have?

The company employs 451 workers across the globe.

How can I contact Northrim BanCorp?

Northrim BanCorp's mailing address is 3111 C Street, ANCHORAGE AK, 99503. The official website for the company is www.northrim.com. The financial services provider can be reached via phone at (907) 562-0062, via email at investors@nrim.com, or via fax at 907-562-1758.

This page (NASDAQ:NRIM) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -